Sort   by:  
 Page size 
UnknownPhospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect.
Not available
S-EPMC2966552 | biostudies-literature
UnknownPhospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice.
Not available
S-EPMC3131469 | biostudies-literature
UnknownThe heterogeneous nucleation of threading dislocations on partial dislocations in III-nitride epilayers.
Not available
S-EPMC7566635 | biostudies-literature
UnknownComparison of the Serum Metabolic Fingerprint of Different Exercise Modes in Men with and without Metabolic Syndrome.
Not available
S-EPMC6631338 | biostudies-literature
UnknownThe novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: an effect mediated by cyclin D1.
Not available
S-EPMC5006213 | biostudies-literature
UnknownEffects of Different Exercise Modes on the Urinary Metabolic Fingerprint of Men with and without Metabolic Syndrome.
Not available
S-EPMC5372208 | biostudies-literature
UnknownPhospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice.
Not available
S-EPMC2949489 | biostudies-literature
UnknownLiquid Phase Isolation of SnS Monolayers with Enhanced Optoelectronic Properties.
Not available
S-EPMC9951343 | biostudies-literature
UnknownHeterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
Not available
S-EPMC10980745 | biostudies-literature
UnknownEfficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Not available
S-EPMC8693692 | biostudies-literature
Sort   by:  
 Page size